biote Corp. Income Statement
BTMD|4 years of annual SEC 10-K data (FY2022-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 4 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$192M
FY2025
Gross Profit
N/A
FY2025
Operating Income
$36M
FY2025
Net Income
$27M
FY2025
biote Corp. reported $192M in revenue and $27M in net income for FY2025. Revenue has grown at a 5.2% compound annual rate over the past 3 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $192.2M | $197.2M | $185.4M | $165.0M |
| SG&A Expense | $101.8M | $107.5M | $98.8M | $171.1M |
| Operating Income | $35.6M | $31.6M | $28.7M | -$60.7M |
| Income Tax | $6.0M | $970.0K | $2.7M | $388.0K |
| Net Income | $27.0M | $3.2M | $3.3M | -$969.0K |
| EPS (Basic) | $0.09 | $0.13 | -$0.12 | -$0.12 |
| EPS (Diluted) | $0.09 | $0.13 | -$0.12 | -$0.12 |
| Shares Outstanding | 34.3M | 25.7M | 8.1M | 58.2M |
| Operating Margin | 18.5% | 16.0% | 15.5% | -36.8% |
| Profit Margin | 14.1% | 1.6% | 1.8% | -0.6% |